NCT07487350Recruiting
Recurrent Visceral Leishmaniasis in HIV Co-Infection
New And Recurrent Visceral Leishmaniasis in HIV Co-Infected Ethiopian Patients: a Cohort Study
Source: ClinicalTrials.gov · Last updated 23 Mar 2026
Brief summary (registry, in English)
The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 17 Mar 2026
- Start date
- 21 Oct 2025
- Primary completion date
- Apr 2027
- Lead sponsor
- Institute of Tropical Medicine, Belgium
- Diseases
- HIV
- NCT number
- NCT07487350
What you commit to
- Study type: Observational
- Planned participants: 20
- From 21 Oct 2025 to the primary completion date, Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not willing to provide written informed consent
- Not willing to adhere to the follow-up visits
- Mentally or physically incapable to participate in the study (to the discretion of the treating physician)
Who the study is looking for
- VL-HIV infection 1.1. VL: microscopically confirmed parasite presence in spleen or bone marrow tissue at first episode or relapse; for known active chronic cases: decision to treat VL 1.2. HIV: confirmed viral infection (new or past)
- ≥18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Gondar Coordinator of this site? Confirm its status | Gonder | Ethiopia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.